Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polyethylene glycol 3350 for colorectal cancer prevention
NCT00828984Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2009
- Primary completion
- Oct 2014
- Modality
- Injectable Hydrogels, Implantable Hydrogels, Biodegradable Polymers
- Countries
- 1
01
Overview
A Phase 2 trial of polyethylene glycol 3350 in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Oct 2009; status: completed.
02
Drugs
polyethylene glycol 3350
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00828984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828984.